Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3685
+0.0024 (0.66%)
At close: Jul 10, 2025, 4:00 PM
0.3650
-0.0035 (-0.95%)
Pre-market: Jul 11, 2025, 7:49 AM EDT
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $8.53 million as of July 11, 2025. Its market cap has decreased by -86.79% in one year.
Market Cap
8.53M
Enterprise Value
-12.63M
1-Year Change
-86.79%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $8.53M, a decrease of -96.67%. That is a compound annual growth rate of -82.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 8.47M | -26.28% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |